Gene · 23091
ZC3H13: zinc finger CCCH-type containing 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ZC3H13: zinc finger CCCH-type containing 13. Genes, record 23091. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23091
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q5T200 | Zinc finger CCCH domain-containing protein 13 | 1,668 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents18
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1076 | Q5T200 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 755 | Q5T200 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15900 | Q5T200 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 755 | Q5T200 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1076 | Q5T200 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15900 | Q5T200 | Espacenet |
| JP 2025024198 A | 2025-02-19 | 17439 | Q5T200 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15900 | Q5T200 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15739 | Q5T200 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 98837 | Q5T200 | Espacenet |
1 to 10 of 18
See all 18 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants369
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ZC3H13 papers | Newest fiscal year |
|---|---|---|---|
| RM1HG008935 | Center for dynamic RNA epitranscriptomes - Renewal | 6 | 2025 |
| R35NS111631 | New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons | 3 | 2025 |
| P50AA022537 | Cross-species investigation of gene networks for ethanol-related behaviors | 2 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 2 | 2025 |
| R01AI125416 | Defining the role of the RNA modification N6-methyladenosine during Flaviviridae virus infection | 2 | 2025 |
| R01CA186702 | Mechanisms of epitranscriptomic regulation in cancer | 2 | 2025 |
| R01CA246130 | Dissecting and Targeting RB1-Mutant Osteosarcoma | 2 | 2025 |
| R01CA259576 | The role of YTHDC1 in normal and malignant hematopoiesis | 2 | 2025 |
| R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 2 | 2025 |
| R01DK129489 | The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic stability in HSPCs | 2 | 2025 |
1 to 10 of 369Source NIH's project files
See all 369 nih grantsPapers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels. | Transl Cancer Res | 2026 | 42724890 | PubTator, text mining | PubMed |
| A m6A/m1A/m5C-related eight-gene signature predicts prognosis and correlates with immune microenvironment in pediatric acute myeloid leukemia. | Transl Pediatr | 2026 | 42591630 | PubTator, text mining | PubMed |
| sFRP-4 regulated by n6‑methyladenosine writer ZC3H13 attenuates sunitinib resistance of renal cell carcinoma via inactivating Wnt/β-catenin pathway. | Sci Rep | 2026 | 42374135 | PubTator, text mining | PubMed |
| WTAP tetramer ensures m6A writer assembly and faithful mitosis. | EMBO Rep | 2026 | 42231024 | PubTator, text mining | PubMed |
| The FOXO3/ZC3H13/SLC3A2 cascade modulates the osteogenic differentiation and ferroptosis of BMSCs. | J Bioenerg Biomembr | 2026 | 42217127 | PubTator, text mining | PubMed |
| Epitranscriptomic silencing of the ZC3H13/m6A axis orchestrates immunosuppressive microenvironment remodeling in renal cell carcinoma via CSF2-mediated MDSCs recruitment. | J Exp Clin Cancer Res | 2026 | 42163390 | PubTator, text mining | PubMed |
| Deletion of GPX8 Enhances Irradiation-Induced Ferroptosis Through m6A Hypomethylation-Mediated Upregulation of ACSL4 in Oral Cancer. | Antioxid Redox Signal | 2026 | 42156324 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A RNA methylation regulators for prognostic risk stratification and immune microenvironment characterization in colorectal cancer. | Open Med (Wars) | 2026 | 42109907 | PubTator, text mining | PubMed |
| ZC3H13-mediated the m6A modification of PAX9 suppresses the progression of reflux esophagitis via improving esophageal epithelial barrier dysfunction. | Gene | 2026 | 42044732 | PubTator, text mining | PubMed |
| Genetic Variations in the M6A Modification Pathway as Potential Predictors of Imatinib Secondary Resistance in Gastrointestinal Stromal Tumors. | J Clin Med | 2026 | 41899107 | PubTator, text mining | PubMed |
1 to 10 of 1,599
See all 1,599 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23091
GET https://conductscience.org/api/genes/v1/23091/patents